Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Degenerative Lumbar Spinal Stenosis: later-stage trial registry

1 of 1 indexed Degenerative Lumbar Spinal Stenosis trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Degenerative Lumbar Spinal Stenosis: 1 US clinical trial tracked, 1 recruiting.

Degenerative Lumbar Spinal Stenosis is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Hospital for Special Surgery, New York, running 1 of these trials.

Enrollment posture brief

Registry condition degenerative-lumbar-spinal-stenosis

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Degenerative Lumbar Spin (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Degenerative Lumbar Spinal Stenosis

Degenerative Lumbar Spinal Stenosis lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Degenerative Lumbar Spinal Stenosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Degenerative Lumbar Spinal Stenosis is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on Degenerative Lumbar Spinal Stenosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Tranexamic Acid 100 MG/ML Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Degenerative Lumbar Spinal Stenosis trials. A trial with sites in several states counts in each.

New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Degenerative Lumbar Spinal Stenosis page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Degenerative Lumbar Spinal Stenosis condition card totals 1 registered trials; most-linked intervention Tranexamic Acid 100 MG/ML; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.